[HTML][HTML] Navigating Novel Uncertainties of COVID-19: The Rise of the JN. 1 Variant

I Altamimi, IM Alabdulkarim, AS Alhumimidi… - Cureus, 2024 - ncbi.nlm.nih.gov
In the shadow of the coronavirus disease 2019 (COVID-19) pandemic, the emergence of
the JN. 1 variant highlights the need for continued vigilance. This Editorial examines the …

Decline in ESBL Production and Carbapenem Resistance in Urinary Tract Infections among Key Bacterial Species during the COVID-19 Pandemic

I Altamimi, K Binkhamis, A Alhumimidi, IM Alabdulkarim… - Antibiotics, 2024 - mdpi.com
The COVID-19 pandemic has led to significant changes in healthcare practices, including
increased antibiotic usage. This study aimed to investigate the impact of the pandemic on the …

Prevalence and associated factors of alexithymia among medical students: A cross-sectional study from Saudi Arabia

…, AH Almadani, SA Alghamdi, IM Alabdulkarim… - Neurosciences …, 2022 - nsj.org.sa
Objectives: To assess the prevalence of alexithymia and its associated factors among medical
students at King Saud University (KSU), Riyadh, Kingdom of Saudi Arabia. Methods: A …

Facile fabrication of novel Ag2S-ZnO/GO nanocomposite with its enhanced photocatalytic and biological applications

…, MM Ibrahim, V Jevtovic, HA AL-Abdulkarim… - Journal of Molecular …, 2022 - Elsevier
Progression in nanotechnology enormously influence on the synthesis of highly proficient
photo materials, which can be used for a number of applications in diverse fields. Herein, a …

Uncaria rhynchophylla mediated Ag/NiO nanocomposites: A new insight for the evaluation of cytotoxicity, antibacterial and photocatalytic applications

…, HA Al-Abdulkarim, V Jevtovic, MM Ibrahim… - Photodiagnosis and …, 2022 - Elsevier
The increase of microbial resistance poses threats to human health. Therefore, efficient
treatment of microbial resistance is a global challenge.. During this study, the Ag/NiO …

A multicenter prospective phase II trial of neoadjuvant epirubicin, cyclophosphamide, and 5-fluorouracil (FEC100) followed by cisplatin–docetaxel with or without …

…, H Jaafar, O Abulkhair, H Al-abdulkarim… - Cancer chemotherapy …, 2016 - Springer
Purpose To evaluate the efficacy and safety profile of the (FEC100) followed by cisplatin/docetaxel
with and without trastuzumab as primary chemotherapy for patients with locally …

[PDF][PDF] Prediction of childhood cancer using APGAR score: A systematic review and meta-analysis

AO Alabdulkarim, M Ibrahim - 2022 - discoveryjournals.org
Background: The etiology of childhood cancer remains unclear, although current research
suggests that the uterine environment has a significant impact. The objective of this review is …

Abstract P1-11-08: A Multicenter Prospective Phase II Trial of Neo-Adjuvant (FEC 100)/Cisplatin-Docetaxel with or without Trastuzumab in Locally Advanced Breast …

…, HN Jaafar, OA Abulkhair, HA Al-Abdulkarim… - Cancer Research, 2010 - AACR
BACKGROUND: To evaluate the efficacy and safety profile of the (FEC100) followed by
cisplatin/docetaxel with or without trastuzumab as primary chemotherapy for patients with locally …

Uncaria rhynchophylla mediated Ag/NiO nanocomposites: A new insight for the evaluation of cytotoxicity, antibacterial and photocatalytic applications

…, HA Al-Abdulkarim, MM Ibrahim… - Photodiagnosis and …, 2021 - ksascholar.dri.sa
The increase of microbial resistance poses threat to the human health. Therefore, the efficient
treatment of the microbial resistance is a global challenge and highly desired to explore it. …

Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance

ME Ibrahim - Annals of clinical microbiology and antimicrobials, 2019 - Springer
Acinetobacter baumannii is an important opportunistic pathogen due to its capabilities for
developing mechanisms of resistance to a wide range of antimicrobial agents including …